
Company valuation, historical trends, and peer comparisons.
According to Herantis Pharma Oyj’s latest financial reports and current stock price. The company's current Enterprise Value is 34.14M. This represents a change of -16.52% compared to the average of 40.90M of the last 4 quarters.
The mean historical Enterprise Value of Herantis Pharma Oyj over the last ten years is 30.39M. The current 34.14M Enterprise Value has changed 12.34% with respect to the historical average. Over the past ten years (40 quarters), HRPMF's Enterprise Value was at its highest in in the December 2025 quarter at 51.85M. The Enterprise Value was at its lowest in in the June 2011 quarter at 0.
Average
30.39M
Median
27.62M
Minimum
19.68M
Maximum
50.91M
Discovering the peaks and valleys of Herantis Pharma Oyj Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 69.48%
Maximum Annual Enterprise Value = 50.91M
Minimum Annual Increase = -47.66%
Minimum Annual Enterprise Value = 19.68M
| Year | Enterprise Value | Change |
|---|---|---|
| 2025 | 50.91M | 69.48% |
| 2024 | 30.04M | 38.43% |
| 2023 | 21.70M | -8.38% |
| 2022 | 23.68M | 0.56% |
| 2021 | 23.55M | -7.82% |
| 2020 | 25.55M | -47.66% |
| 2019 | 48.82M | 61.36% |
| 2018 | 30.26M | 1.89% |
| 2017 | 29.69M | 50.91% |
| 2016 | 19.68M | 65.46% |
The current Enterprise Value of Herantis Pharma Oyj (HRPMF) is less than than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
34.22M
5-year avg
29.98M
10-year avg
30.39M
Herantis Pharma Oyj’s Enterprise Value is less than Oncopeptides AB (publ) (691.89M), less than Biostage, Inc. (40.73M), less than Mindset Pharma Inc. (66.42M), less than Goodness Growth Holdings, Inc. (186.55M), less than Abliva AB (publ) (683.00M), greater than Karolinska Development AB (publ) (-10745115.00), less than Elegance Optical International Holdings Limited (166.01M), greater than Relief Therapeutics Holding AG (23.87M), less than Small Pharma Inc. (34.49M), less than SymBio Pharmaceuticals Limited (2.92B),
| Company | Enterprise Value | Market cap |
|---|---|---|
| 691.89M | $55.98M | |
| 40.73M | $57.82M | |
| 66.42M | $54.51M | |
| 186.55M | $61.05M | |
| 683.00M | $45.13M | |
| -10745115.00 | $68.85M | |
| 166.01M | $63.38M | |
| 23.87M | $44.94M | |
| 34.49M | $37.51M | |
| 2.92B | $13.26M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Herantis Pharma Oyj using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Herantis Pharma Oyj or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Enterprise Value?
How can you use the Enterprise Value?
What is Herantis Pharma Oyj's Enterprise Value?
What is the highest Enterprise Value for Herantis Pharma Oyj (HRPMF)?
What is the 3-year average Enterprise Value for Herantis Pharma Oyj (HRPMF)?
What is the 5-year average Enterprise Value for Herantis Pharma Oyj (HRPMF)?
How does the current Enterprise Value for Herantis Pharma Oyj (HRPMF) compare to its historical average?